The effects of clinical depression and depressive symptoms on treatment adherence

Patient Treatment Adherence: Concepts, Interventions, and Measurement

Volumn , Issue , 2005, Pages 275-305

  Gonzalez, Jodi M ^a   Williams Jr , John W ^b  

^a UTHealth Medical School   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33044493040     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9781410615626     Document Type: Chapter

References (125)

1. Katon W, Von Korff M, Lin E, Bush T, Ormel J. Adequacy and duration of antidepressant treatment in primary care. Medi Care. 1992;30(1):67-76.
2. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder; results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095-3105.
3. Doebbling CC. Epidemiology, risk factors, and prevention. In: Levinson JL, ed. Depression. Philadelphia, PA; American College of Physicians; 2000:23-45.
4. Murray CJ, Lopez AD. The Global Burden of Disease, ed. H.U. Press. 1996, Cambridge, MA.
5. Unutzer J, Patrick DL, Diehr P, Simon G, Grembowski D, Katon w. Quality adjusted life years in older adults with depressive symptoms and chronic medical disorders. Int Psychogeriatr. 2000;12(1):15-33.
6. Kroenke K. A 75-year-old man with depression. JAMA. 2002;287(12):1568-1576.
7. Sullivan MD, LaCroix AZ, Baum C, Grothaus LC, Katon WJ. Functional status in coronary artery disease; a one-year prospective study of the role of anxiety and depression. Am J Med. 1997;103:348-356.
8. Barefoot JC, Helms MJ, Mark DB, et al. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol. 1996;78(6):613-617.
9. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation. 1995;91(4):999-1005.
10. deGroot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med. 2001;63: 619-630.
11. Lustman PJ, Anderson RJ, Freedland KE, et al. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care. 2000;23:934-942.
12. Covinsky KE, Kahana E, Chin MH, Palmer RM, Fortinsky RH, Landefeld CS. Depressive symptoms and 3-year mortality in older hospitalized medical patients. Ann Intern Med. 1999;130(7):563-569.
13. Katon W. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry. 2003;54: 216-226.
14. Sheline Y. Neuroimaging studies of mood disorder effects on the brain. Biol Psychiatry. 2003;54:338-352.
15. Krishnan KR. Vascular Disease and Depression. Paper presented at Psychiatry Grand Rounds of the University of Texas Health Science Center, San Antonio, Texas (November 4, 2003).
16. Nemeroff CB. The neurobiology of depression. Sci Am. 1998;278:42-49.
17. McEwen B. Mood disorders and allostatic load. Biol Psychiatry. 2003;54:200-207.
18. Di Matteo R, Lepper H, Croghan T. Depression is a risk factor for noncompliance with medical treatment: Meta analysis of the effects of anxiety and depression on patient adherence. Arch Int Med. 2000;160:2101-2107.
19. Blumenthal JA, Williams RS, Wallace AG, Williams RB, Needles TL. Physiological and psychological variables predict compliance to prescribed exercise therapy in patients recovering from myocardial infarction. Psychosom Med. 1982; 44(6):519-527.
20. Carney R, Freedland K, Eisen S, Rich MW, Jaffe AS. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol. 1995;14(1):88-90.
21. Carney R, Freedland K, Miller G, et al. Depression as a risk factor for cardiac mortality and morbidity: A review of potential mechanisms. J Psychosom Res. 2002;53:897-902.
22. Druss BG, Bradford DW, Rosenheck RA, Radford MJ, Krumholz HM. Mental disorders and use of cardiovascular procedures after myocardial infarction. JAMA. 2000;283:506-511.
23. Ziegelstein R, Fauerbach J, Stevens S, Romanelli J, Richter DP, Bush DE. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Int Med. 2000;160: 1818-1823.
24. Romanelli J, Fauerbach J, Bush D, Ziegelstein RC. The significance of depression in older patients after myocardial infarction. J Am Geriatr Soc. 2002;50: 817-822.
25. Dorn J, Naughton J, Imamura D, et al. Correlates of compliance in randomized exercise trial in myocardial infarction patients. Med Sci Sports Exercise. 2001; 33(7):1081-1089.
26. Irvine J, Baker B, Smith J, et al. Poor adherence to placebo or amiodarone therapy predicts mortality: results from the CAMIAT study. Psychosom Med. 1999;61: 566-575.
27. Ford F, Hunter M, Hensley M, et al. Hypertension and asthma: psychological aspects. Soc Sci Med. 1989;29(1):79-84.
28. Wang P, Bohn R, Knight E, Glynn RJ, Mogun H, Avorn J. Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med. 2002;17:504-511.
29. Davies S, Jackson P, Ramsay L, Ghahramani P. Drug intolerance due to nonspecific adverse effects related to psychiatric morbidity in hypertensive patients. Arch Intern Med. 2003;163:592-600.
30. Ciechanowski P, Katon W, Russon J. Depression and diabetes: Impact of depressive symptoms on adherence, function and costs. Arch Intern Med. 2000;160(21): 3278-3285.
31. Ciechanowski P, Katon WJ, Russo JE, Hirsch IB. The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. Gen Hosp Psychiatry. 2003;25(4):246-252.
32. Van Tilburg M, McCaskill C, Lane J, et al. Depressed mood is a factor in glycemic control in type 1 diabetes. Psychosom Med. 2001;63:551-555.
33. Mazze RS, Lucido D, Shamoon H. Psychological and social correlates of glycemic control. Diabetes Care. 1984;7(4):360-366.
34. DeOreo P. Hemodialysis patient-assessed functional health status predicts continued survival, hospitalization, and dialysis-attendance compliance. Am J Kidney Dis. 1997;30(2):204-212.
35. Kimmel PL, Peterson RA, Weihs KL, et al. Behavioral compliance with dialysis prescriptions in hemodialysis patients. J Am Soc Nephrol. 1995;5:1826-1834.
36. Lopes A, Bragg J, Young E, et al. Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int. 2002;62:199-207.
37. Kimmel P, Peterson R, Weihs K, et al. Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis outpatients. Kidney Int. 2000;57:2093-2098.
38. Knight E, Ofsthun N, Teng M, Lazarus JM, Curhan GC. The association between mental health, physical function and hemodialysis mortality. Kidney Int. 2003;63:1843-1851.
39. Singh N, Squier C, Sivek C, Wagener M, Nguyen MH, Yu VL. Determinants of compliance with antiretroviral therapy in patients with immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care. 1996;8(3):261-269.
40. Bogart L, Kelly J, Catz S, Sosman JM. Impact of medical and nonmedical factors on physician decision making for HIV/AIDS antiretroviral treatment. J Acquir Immune Defic Syndr. 2000;23(5):396-404.
41. Turner B, Laine C, Cosler L, Hauck WW. Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users. J Gen Int Med. 2003;18:248-257.
42. Starace F, Ammassari A, Trotta M, et al. Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31:S136-S139.
43. Bing E, Burnam A, Longshore D, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001;58:721-728.
44. Fernando S, Evans S, Goggin K, Sewell M, Fishman B, Rabkin J. Fatigue in HIV illness: Relationship to depression, physical limitations and disability. Psychosom Med. 1998;60:759-764.
45. Rabkin J, Wagner G, Rabkin R. Fluoxetine treatment for depression in patients with HIV and AIDS. Am J Psychiatry. 1999;156:101-107.
46. Ickovics J, Hamburger M, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: Longitudinal analysis from the HIV epidemiology research study. JAMA. 2001;285(11):1466-1474.
47. Powell-Cope GM, White J, Henkelman EJ, Turner BJ. Qualitative and quantitative assessments of HAART adherence of substance-abusing women. AIDS Care. 2003;15(2):239-249.
48. Moore J, Schuman P, Schoenbaum E, Solomon L, Smith D. Severe adverse life events and depressive symptoms among women with, or at risk for, HIV infection in four cities in the United States of America. AIDS. 1999;13:2459-2468.
49. Spire B, Duran S, Souville M, et al. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach. Soc Sci Med. 2002;54:1481-1496.
50. Lerman C, Kash K, Stefanek M. Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior. J Natl Cancer Inst Monogr. 1994;16:171-176.
51. Siegler I, Feaganes J, Rimer B. Predictors of adoption of mammography in women under age 50. Health Psychol. 1995;14(3):274-278.
52. Banks E, Beral V, Cameron R, et al. Comparison of various characteristics of women who do and do not attend for breast cancer screening. Breast Cancer Res. 2002;4(1):R1.
53. Haynes RB, Montague P, Oliver T, McKibbon KA, Brouwers MC, Kanani R. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev. 2000;(2):CD000011.
54. Ruscher SM, de Wit R, Mazmanian D. Psychiatric patients' attitudes about medication and factors affecting noncompliance. Psychiatr Serv. 1997;48(1):82-85.
55. Johnson D. Depression: treatment compliance in general practice. Acta Psychiatr Scand. 1981;290:447-453.
56. Lin EHB, Von Korff M, Katon W, et al. The role of the primary care physician in patients' adherence to antidepressant therapy. Med Care. 1995;33(1):67-74.
57. Linden M, Gothe H, Dittman R, Schaaf B. Early termination of antidepressant drug treatment. J Clin Psychopharmacol. 2000;20(5):523-530.
58. Maidment R, Livingston G, Katona C. Just keep taking the tablets: Adherence to antidepressant treatment in older people in primary care. Int J Geriatr Psychiatry. 2002;17:752-757.
59. Demyttenaere K, Enzlin P, Dewe W, et al. Compliance with antidepressants in a primary care setting, 1: beyond lack of efficacy and adverse events. J Clin Psychiatry. 2001;62(S22):30-33.
60. Sleath B, Wurst K, Lowery T. Drug information sources and antidepressant adherence. Community Ment Health J. 2003;39(4):359-368.
61. Dietrich A, Oxman T, Burns M, Winchell CW, Chin T. Application of a depression management office system in community practice: a demonstration. J Am Board Fam Pract. 2003;16:107-114.
62. Keller M, Hirschfeld R, Demyttenaere K, Baldwin DS. Optimizing outcomes in depression: focus on antidepressant compliance. Int Clin Psychopharmacol. 2002; 17:265-271.
63. Demyttenaere K, Haddad P, Compliance with antidepressant therapy and antidepressant medications. Acta Psychiatr Scand. 2000;S403:50-56.
64. Hotopf M, Hardy R, Lewis G. Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity. Br J Psychiatry. 1997;170:120-127.
65. MacGillivray S, Arroll B, Hatcher S, et al. Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: a systematic review and meta-analysis. BMJ. 2003;326(7397):1014.
66. Thompson C, Peveler R, Stephenson D, McKendrick J. Compliance with antidepressant medication in the treatment of major depressive disorder in primary care: a randomized, comparison of fluoxetine and a tricyclic antidepressant. Am J Psychiatry. 2000;157(3):338-343.
67. Williams JW Jr., Mulrow CD, Chiquette E, Noel PH, Aguilar C, Cornell J. A systematic review of newer pharmacotherapies for depression in adults: evidence report summary. Ann Intern Med. 2000;132(9):743-756.
68. Tai-Seale M, Croghan T, Obenchain R. Determinants of antidepressant treatment compliance: implications for policy. Med Care Res Rev. 2000;57(4): 491-512.
69. Basco M, Rush J. Compliance with pharmacotherapy in mood disorders. Psychiatr Ann. 1995;25(5):269-279.
70. Orleans C, George L, Houpt J, Brodie HK. How primary care physicians treat psychiatric disorders: a national survey of family practitioners. Am J Psychiatry. 1985;142(1):52-57.
71. Williams J, Rost K, Dietrich AJ, Ciotti MC, Zyzanski SJ, Cornell J. Primary care physicians' approach to depressive disorders. Effects of physician specialty and practice structure. Arch Fam Med. 1999;8(1):57-67.
72. Gallo J, Meredith L, Gonzales J, et al. Do family physicians and internists differ in knowledge, attitudes and self-reported approaches for depression? Int J Psychiatry Med. 2002;32(1):1-20.
73. Dobscha S, Delucchi K, Young M. Adherence with referrals for outpatient follow-up from a VA psychiatric emergency room. Community Ment Health J. 1999;35(5):451-458.
74. Grunebaum M, Luber P, Callahan M, Leon AC, Olfson M, Portera L. Predictors of missed appointments for psychiatric consultations in a primary care clinic. Psychiatr Serv. 1996;47(8):848-852.
75. Koshes R, Rothberg J. Compliance with consultations in a military psychiatry clinic. Mil Med. 1994;159(4):310-313.
76. Minoletti A, Perez E, Blouin A. Compliance with referrals from psychiatric emergency services to ambulatory facilities: a 20-year literature review. Am J Soc Psychiatry. 1984;4(2):57-61.
77. Peeters F, Bayer H. No-show for initial screening at a community mental health centre: rate, reasons and further help-seeking. Soc Psychiatry Psychiatr Epidemiol. 1999;34:323-327.
78. Sparr L, Moffitt B, Ward M. Missed psychiatric appointments: who returns and who stays away. Am J Psychiatry. 1992;150(5):801-805.
79. Solomon P, Gordon B. Outpatient compliance of psychiatric emergency room patients by presenting problems. Psychiatr Q. 1988;59(4):271-283.
80. McGlade K, Bradley T, Murphy G, Lundy GP. Referrals to hospital by general practitioners: A study of compliance and communication. BMJ. 1988;297: 1246-1248.
81. Reuben D, Maly R, Hirsch S, et al. Physician implementation of and the patient adherence to recommendations from comprehensive geriatric assessment. Am J Med. 1996;100:444-451.
82. Olfson M. Primary care patients who refuse specialized mental health services. Arch Intern Med. 1991;151:129-132.
83. Farid B, Alapont E. Patients who fail to attend their first psychiatric outpatient appointment: non-attendance or inappropriate referral? J Ment Health. 1993;2: 81-83.
84. Killaspy H, Banerjee S, King M, Lloyd M. Non-attendance at psychiatric outpatient clinics: communication and implications for primary care. Br J Gen Pract. 1999;49:880-883.
85. Killaspy H, Banerjee S, King M, Lloyd M. Prospective controlled study of psychiatric outpatient non-attendance. Br J Psychiatry. 2000;176:160-165.
86. Neeleman J, Mikhail W. A case-control study of GP and patient-related variables associated with non-attendance at new psychiatric out-patient appointments. J Ment Health. 1997;6(3):301-306.
87. Livianos-Aldana L, Vila-Gomez M, Rojo-Moreno L, Luengo-Lopez MA. Patients who miss initial appointments in community psychiatry? A Spanish community analysis. Int J Soc Psychiatry. 1999;45(3):198-206.
88. Lambert M. Bergin and Garfield's Handbook of Psychotherapy and Behavior Change. New York: John Wiley and Sons; 2004.
89. Garland A, Scott J. Cognitive therapy for depression in women. Psychiatr Ann. 2002;32(8):465-476.
90. Paykel E. Psychotherapy, medication combinations, and compliance. J Clin Psychiatry. 1995;56(S1):24-30.
91. Linden W, Stossel C, Maurice J. Psychosocial interventions for patients with coronary artery disease. A meta-analysis. Arch Intern Med. 1996;156:745-752.
92. Glassman A, O'Connor C, Califf R, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002;288(6):701-709.
93. Writing Committee for the ENRICHD Investigators. Effects of treating depression and low perceived social support on clinical events after myocardial infarction. The Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA. 2003;289(23):3106-3116.
94. Lustman PJ, Griffith LS, Freedland KE, Kissel SS, Clouse RE. Cognitive behavior therapy for depression in type 2 diabetes mellitus: a randomized, controlled trial. Ann Intern Med. 1998;129(8):613-621.
95. Lustman PJ, Griffith LS, Clouse RE, et al. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med. 1997;59:241-250.
96. Lustman PJ, Freedland KE, Griffith LS, Clouse RE. Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care. 2000;23:618-623.
97. Angelino A, Treisman G. Management of psychiatric disorders in patients infected with human immunodeficiency virus. HIV/AIDS. 2001;33:847-856.
98. Peveler R, George C, Kinmonth AL, Campbell M, Thompson C. Effect of antidepressant drug counseling and information leaflets on adherence to drug treatment in primary care: randomized controlled trial. BMJ. 1999;319: 612-615.
99. Badamgarav E, Weingarten S, Henning J, et al. Effectiveness of disease management programs in depression: a systematic review. Am J Psychiatry. 2003; 160(12):2080-2090.
100. Katon W, Von Korff M, Lin E, et al. Collaborative management to achieve treatment guidelines: impact on depression in primary care. JAMA. 1995;273: 1026-1031.
101. Simon G, Von Korff M, Rutter C, Wagner E. Randomised trial of monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care. BMJ. 2000;320:550-554.
102. Hunkeler E, Meresman J, Hargreaves W, et al. Efficacy of nurse telehealth care and peer support in augmenting treatment of depression in primary care. Arch Fam Med. 2000;9:700-708.
103. Katzelnick D, Simon G, Pearson S, et al. Randomized trial of a depression management program in high utilizers of medical care. Arch Fam Med. 2000;9: 345-351.
104. Rost K, Nutting P, Smith J, Werner J, Duan N. Improving depression outcomes in community primary care practice. J Gen Intern Med. 2001;16(3):143-149.
105. Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A. Improving chronic illness care: translating evidence into action. Health Aff (Millwood). 2001;20(6):64-78.
106. Kehoe W. Pharmacists and the treatment of depression. Am J Health Syst Pharm. 2002;59(16):1509.
107. Bultman D, Svarstad B. Effects of physician communication style on client medication beliefs and adherence with antidepressant treatment. Patient Educ Couns. 2000;40:173-185.
108. Finley P, Rens H, Pont J, et al. Impact of a collaborative pharmacy practice model on the treatment of depression in primary care. Am J Health Syst Pharm. 2002;59(16):1518-1526.
109. Boudreau D, Capoccia K, Sullivan S, et al. Collaborative care model to improve outcomes in major depression. Ann Pharmacother. 2002;36:585-591.
110. Furukawa T, Streiner D, Young T. Is antidepressant-benzodiazepine combination therapy clinically more useful? A meta-analytic study. J Affect Disord. 2001; 65:173-177.
111. Larsen D, Nguyen T, Green R, et al. Enhancing the utilization of outpatient mental health services. Community Ment Health J. 1983;19(4):305-320.
112. Daley D, Salloum I, Zuckoff A, Kirisci L, Thase ME. Increasing treatment adherence among outpatients with depression and cocaine dependence: results of a pilot study. Am J Psychiatry. 1998;155(11):1611-1613.
113. Chen A. Noncompliance in community psychiatry: a review of clinical interventions. Hosp Commun Psychiatry. 1991;42(3):282-287.
114. Tinsley H, Bowman S, Ray S. Manipulation of expectancies about counseling and psychotherapy: Review and analysis of expectancy manipulation strategies and results. Journal of Counseling Psychology. 1988;35(1):99-108.
115. Karasu TB, Gelenberg A, Merriam AE, Wang P. American Psychiatric Association practice guideline for the treatment of patients with major depressive disorder. Am J Psychiatry. 2000 Apr;157(4 Suppl):1-45.
116. Radloff S. The CES-D Scale: a self-report depression scale in the general population. Appl Psychol Meas. 1977;1:385-401.
117. Gatz M, Johansson B, Pedersen N, Berg S, Reynolds C. A cross-national selfreport measure of depressive symptomatology. Int Psychogeriatr. 1993;5: 147-156.
118. Hertzog C, Van Alstine J, Usasl P, Hultsch DF, Dixon R. Measurement properties of the center for epidemiological studies depression scale (CES-D) in older populations. J Consult Clin Psychol. 1990;2:64-72.
119. Sheehan T, Fifield J, Reisine S, et al. The measurement structure of the center for epidemiological studies depression scale. J Pers Assess. 1995;64:507-521.
120. Felton B, Revenson T, Hinrichsen G. Stress and coping in the explanation of psychological adjustment among chronically ill adults. Soc Sci Med. 1984; 18(10):889-898.
121. Adams S, Pill R, Jones A. Medication, chronic illness and identity: the perspective of people with asthma. Soc Sci Med. 1997;45(2):189-201.
122. Katon W, Robinson P, Von Korff M, et al. A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry. 1996;53: 924-932.
123. Katon W, Von Korff M, Lin E, et al. Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial. Arch Gen Psychiatry. 1999;56:1109-1115.
124. Wells KB, Sherbourne C, Schoenbaum M, et al. Impact of disseminating quality improvement programs for depression in managed primary care. JAMA. 2000;283:212-220.
125. Unutzer J, Katon W, Callahan CM, et al. Collaborative care management of late-life depression in primary care: a randomized controlled trial. JAMA. 2002;288:2836-2845.